SHRIRAMFIN

: Balance Sheet Boost, Valuation Comfort Despite Dilution

gained after announcing that MUFG Bank Ltd will acquire a 20% stake through a preferential allotment of 471 million shares at ₹840 each. The deal, valued at over ₹40,000 crore, strengthens Shriram’s capital base and offers MUFG a strategic entry into India’s NBFC space. For shareholders, the infusion enhances balance sheet resilience and could trigger rating upgrades, while equity dilution is expected to have only a marginal impact on earnings per share. 1. MUFG’s Strategic Choice of NBFC over Banks Private banks face a 26% voting rights cap and regulatory requirements like CRR, SLR, and priority sector lending, which compress RoA. NBFCs, by contrast, enjoy higher RoA and fewer restrictions. Shriram Finance, with only 25% promoter holding via an employee trust, offers MUFG scope to increase its stake without promoter resistance. 2. Capital Infusion Strengthens Balance Sheet The deal lifts Shriram’s tier‑1 capital ratio from 20% to 36% (Q2FY26), providing a strong buffer for growth. A rating upgrade from AA+ is possible, which would lower borrowing costs and improve funding flexibility. 3. Valuation Perspective for MUFG Attractive entry valuation: Shriram trades at 13x FY28e P/E, versus Cholamandalam’s 17x. While Shriram’s earnings CAGR is projected at 18% (FY26‑28) versus Cholamandalam’s 25%, the growth differential is already reflected in valuations. 4. Limited EPS Impact from Dilution Even with 25% equity dilution, incremental profit from interest savings (~₹2,700 crore in FY27) could offset the impact. This represents 24% of FY27 consensus PAT, suggesting dilution will be marginal for EPS. 5. Peer Comparison and Strategic Positioning Shriram’s market cap stands at ₹1.7 trillion, slightly ahead of Cholamandalam’s ₹1.4 trillion. The MUFG partnership enhances Shriram’s credibility, funding access, and potential for future stake increases, positioning it as a preferred NBFC play.